 Kymera unveiled promising results for its skin-disease treatment on Wednesday, snagging interest from Sanofi and sending KYMR stock flying. The post Why Small Biotech Kymera Just Snagged Sanofis Interest And Surged 28 appeared first on Investors Business Daily. 